Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-16 CONN GREGORY Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +299,567 299,567
2026-11-16 BEDU-ADDO FRANK President/CEO Grant or award · Employee Stock Option (Right to Buy) +2,698,978 2,698,978
2026-11-16 BEDU-ADDO FRANK President/CEO Grant or award · Employee Stock Option (Right to Buy) +16,556,733 16,556,733
2026-11-16 Brown Spencer D. Senior VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +150,000
2026-11-16 PDS Biotechnology Corp Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +299,567 299,567
2026-11-16 Shepard Kirk V. Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +750,000 750,000
2026-11-16 Trochimiuk Janetta Principal Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2026-10-18 Dawson John Andrew Director Grant or award · Stock Option (Right to Buy) +22,700 22,700
2026-10-18 Ramsdell Deborah Director Grant or award · Stock Option (Right to Buy) +22,700 22,700
2026-10-18 Wendel Bruce Director Grant or award · Stock Option (Right to Buy) +22,700 22,700
2026-01-12 BEDU-ADDO FRANK President/CEO Grant or award · Employee Stock Option (Right to Buy) +548,782 548,782
2026-01-12 CONN GREGORY Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2026-01-12 Shepard Kirk V. Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2026-01-12 Boesgaard Lars Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2026-01-12 Brown Spencer D. Senior VP, General Counsel Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2026-01-12 Toutain Stephan Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2026-01-12 Freitag Gregory Gene Director Grant or award · Employee Stock Option (Right to Buy) +54,876 54,876
2026-01-12 Iliev Ilian Director Grant or award · Employee Stock Option (Right to Buy) +54,876 54,876
2026-01-12 Ali-Jackson Kamil Director Grant or award · Employee Stock Option (Right to Buy) +54,876 54,876
2026-01-12 BRAWLEY OTIS W Director Grant or award · Employee Stock Option (Right to Buy) +54,876 54,876

Page 1 of 18 · 346 trades